WEBUY GLOBAL LTD. Expands Second Collaboration with CTG MICE Service Company Limited on AI Travel Devices

(NASDAQ:WBUY), Singapore, Jan. 12, 2026 (GLOBE NEWSWIRE) — WEBUY GLOBAL LTD (Nasdaq: WBUY) (the “Company” or “Webuy”) today announced an expanded collaboration with CTG MICE Service Company Limited, a subsidiary of China Tourism Group, to support the planned deployment of its AI-powered smart travel guide devices across major museums and cultural attractions in China. China […]

Copper Quest and i2i Enter Into Corporate Marketing and Investor Awareness Agreement

(CNSX:CQX),(OTC US:IMIMF),(Other OTC:IMIMF),(Boerse Frankfurt – Freiverkehr:3MX0),(CNSX:CQX.CN),(Boerse Frankfurt – Freiverkehr:3MX0.F), VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company“) is pleased to announce that it has entered into an agreement (the “Agreement“) with i2i Marketing Group, LLC (“i2i“), a Florida-based firm,

Profound Surpasses 2025 TULSA-PRO(R) Installed Base Goal

(TSX:PRN),(NASDAQ:PROF), TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that its TULSA-PRO(R) system installed base stood at 78 as of December 31, 2025 —

Condor Provides an Operations Update for Uzbekistan

(TSX:CDR), CALGARY, Alberta, Jan. 12, 2026 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based, internationally focused energy transition company with active operations in Central Asia is pleased to provide an update on its Uzbekistan operations. Average daily production increased 5.6% to 10,534 boepd for the fourth quarter of

Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones

(NASDAQ:ELUT), Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at year-end GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a corporate update and outlined upcoming development milestones for

Bakkt Agrees to Acquire Distributed Technologies Research Ltd.

(NYSE:BKKT), – Acquisition advances Bakkt's global stablecoin settlement and programmable payments strategy– Company to operate as “Bakkt, Inc.” effective January 22, 2026– Investor Day scheduled for March 17, 2026 at the New York Stock Exchange NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT) today announced that

Sunderstorm Acquires Lime to Expand House of Brands Into Pre-Rolls

Strategic acquisition extends Sunderstorm’s platform into one of cannabis’ largest categories, driving sustainable, profitable growth Sunderstorm, a global California-based leader in premium cannabis edibles and vapes and the company behind the widely recognized KANHA brand, today announced the acquisition of Lime, one of California’s most respected pre-roll brands. The transaction advances Sunderstorm’s long-term growth strategy

Mereo BioPharma Provides Corporate Update

(NasdaqGM:MREO), Additional data analyses from Orbit and Cosmic Phase 3 studies of setrusumab (UX143) in osteogenesis imperfecta ongoing to determine potential path forward for the program Cash balance of approximately $41 million as of December 31, 2025; runway guidance updated to mid-2027 LONDON, Jan. 12, 2026 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO)

Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibitor

(NASDAQ:CVKD), SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the significant and persistent unmet medical need in heparin-induced thrombocytopenia (HIT) and underscored the promise of its recently acquired investigational drug candidate, VLX-1005, the first

Alliance of Channel Women Announces 2026 Awards Program Honoring Contributions to Advancing Women in Tech Channels

Nominations Open Through February 27, 2026; Winners Announced April 13, 2026, at Channel Partners Conference & Expo, Las Vegas The Alliance of Channel Women (ACW), a not-for-profit organization dedicated to accelerating the growth of female leaders in the technology channel, today announced that nominations are open for its prestigious ACW Awards Program recognizing individual and

Scroll to Top